The Current Ratio as of November 2024 (TTM) for Infinity Pharmaceuticals, Inc. (INFI) is 2.96

According to Infinity Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.96. This represents a change of 11.65% compared to the average of 2.65 of the last 4 quarters.

Infinity Pharmaceuticals, Inc. (INFI) Historical Current Ratio (quarterly & annually)

How has INFI Current Ratio performed in the past?

The mean historical Current Ratio of Infinity Pharmaceuticals, Inc. over the last ten years is 5.41. The current 2.96 Current Ratio has changed 5.37% with respect to the historical average. Over the past ten years (40 quarters), INFI's Current Ratio was at its highest in in the March 2021 quarter at 11.56. The Current Ratio was at its lowest in in the June 2023 quarter at 1.65.

Infinity Pharmaceuticals, Inc. (INFI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Infinity Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Infinity Pharmaceuticals, Inc. (INFI) Average Current Ratio

How has INFI Current Ratio performed in the past?

The current Current Ratio of Infinity Pharmaceuticals, Inc. (INFI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Infinity Pharmaceuticals, Inc. (INFI) Current Ratio vs. Peers

How is INFI’s Current Ratio compared to its peers?

Infinity Pharmaceuticals, Inc.’s Current Ratio is less than NextCure, Inc. (9.07), less than Chimerix, Inc. (6.33), less than Eledon Pharmaceuticals, Inc. (6.53), greater than Kiromic BioPharma, Inc. (0.22), less than Neoleukin Therapeutics, Inc. (15.33), greater than CytomX Therapeutics, Inc. (1.04), greater than Assembly Biosciences, Inc. (2.36), less than Instil Bio, Inc. (12.90), less than Nuvation Bio Inc. (9.57), less than Generation Bio Co. (6.34), less than Kronos Bio, Inc. (8.32), less than Erasca, Inc. (11.00), less than C4 Therapeutics, Inc. (6.31), less than Edgewise Therapeutics, Inc. (26.35), less than Lyra Therapeutics, Inc. (3.64), less than Trevi Therapeutics, Inc. (7.38), greater than SQZ Biotechnologies Company (1.37), less than Protara Therapeutics, Inc. (9.85), greater than TRACON Pharmaceuticals, Inc. (0.66), greater than Aditxt, Inc. (0.09), greater than NeuroBo Pharmaceuticals, Inc. (2.41), less than Dermata Therapeutics, Inc. (7.11), less than Unicycive Therapeutics, Inc. (3.61), greater than Revelation Biosciences, Inc. (1.64),

Build a custom stock screener for Infinity Pharmaceuticals, Inc. (INFI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Infinity Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Infinity Pharmaceuticals, Inc. (INFI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Infinity Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.